The Program allows patients with serious rare diseases to have access to pre-market drugs and devices, if the Sponsor agrees to this under their expanded access policy
View this resource Bookmark this resource
US Expanded Access Program
Published by IRDiRC
Research and Drug DevelopmentRegulatory AffairsOrphan DrugEarly Access SupportOrphan MedicineExpanded Accesss Programme